Skip to content

Comparison of intravenous Dexamethasone versus perineural Dexamethasone as an adjuvant to Bupivacaine in TAP block for post caesarean analgesia.

Comparative evaluation of intravenous Dexamethasone versus perineural Dexamethasone as an adjuvant to Bupivacaine in transverse abdominis plane block for post caesarean analgesia. - NIL

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/08/057064
Enrollment
100
Registered
2023-08-30
Start date
Unknown
Completion date
Unknown
Last updated
2023-09-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: NIL: NIL Control Intervention1: A comparative evaluation to study the effects of intravenous dexamethasone versus perineural dexamethasone as an adjuvant to bupivacaine in transversus

Sponsors

Department of Anaesthesiology, School of Medical Sciences and Research, Sharda Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients scheduled for elective caesarean section under spinal anesthesia. 2. ASA Grade 2.

Exclusion criteria

Exclusion criteria: 1. Coagulopathy or patients on anti-coagulation treatment. 2. History of allergy to local anaesthetic. 3. Infection at the injection site. 4. Obese patients and patients having pregnancy-induced hypertension and uncontrolled diabetes mellitus.

Design outcomes

Primary

MeasureTime frame
To compare the duration & intensity of postoperative analgesia in the two groups.Timepoint: Post operative 24 hours.

Secondary

MeasureTime frame
1. To compare patient satisfaction after postoperative analgesia in the two groups. 2. To compare post-operative side effects like nausea, vomiting & haemodynamics instability in the two groups. Timepoint: 24 hours Post operative period.

Countries

India

Contacts

Public ContactDr Harsh Vardhan

School of Medical Sciences and Research

harshvardhan23@hotmail.com9871952687

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026